Diploma PLC (DPMAY)
OTCMKTS
· Delayed Price · Currency is USD
252.65
-3.10 (-1.21%)
Jun 13, 2025, 4:00 PM EDT
Revenue by Product
Fiscal year is October - September.
Year Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | NaN - NaN |
---|---|---|---|---|---|---|
Controls | 652.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Controls Growth | 38.58% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Seals | 489.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Seals Growth | 39.82% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Life Sciences | 221.90M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Life Sciences Growth | 13.91% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is October - September.
Year Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | NaN - NaN |
---|---|---|---|---|---|---|
Controls Operating Profit | 132.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Controls Operating Profit Growth | 79.73% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Seals Operating Profit | 62.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Seals Operating Profit Growth | 41.71% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Life Sciences Operating Profit | 35.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Life Sciences Operating Profit Growth | -7.39% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate Operating Profit | -22.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate Operating Profit Growth | 46.13% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is October - September.
Year Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | NaN - NaN |
---|---|---|---|---|---|---|
United Kingdom | 273.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United Kingdom Growth | 27.73% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of Europe | 267.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of Europe Growth | 42.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
North America | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
North America Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of World Revenue (Pre-FY2023 Reporting) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of World Revenue (Pre-FY2023 Reporting) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
USA | 626.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
USA Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of World | 196.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of World Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is October - September.
Year Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | NaN - NaN |
---|---|---|---|---|---|---|
United Kingdom Adjusted Operating Profit | 23.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United Kingdom Adjusted Operating Profit Growth | -84.03% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of Europe Adjusted Operating Profit | 53.90M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of Europe Adjusted Operating Profit Growth | 49.67% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
North America Adjusted Operating Profit | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
North America Adjusted Operating Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of World Adjusted Operating Profit (Pre-FY2023 Reporting) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of World Adjusted Operating Profit (Pre-FY2023 Reporting) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
USA Adjusted Operating Profit | 165.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
USA Adjusted Operating Profit Growth | 87.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of World Adjusted Operating Profit | 42.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of World Adjusted Operating Profit Growth | -5.58% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Controls Adjusted Operating Profit | 144.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Controls Adjusted Operating Profit Growth | 77.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Seals Adjusted Operating Profit | 87.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Seals Adjusted Operating Profit Growth | 18.77% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Life Sciences Adjusted Operating Profit | 46.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Life Sciences Adjusted Operating Profit Growth | 4.78% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate Adjusted Operating Profit | -22.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate Adjusted Operating Profit Growth | 94.64% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Life Sciences Organic Growth | 6.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Seals Organic Growth | 1.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Controls Organic Growth | 10.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Group Organic Growth | 6.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|